Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Dr. Pappolla is currently a Professor appointment with the Department of Neurology at the University of Texas Medical Branch in Galveston . Dr. Pappolla received his MD degree from the University of Buenos Aires in Argentina in 1978. His training includes a PhD Doctorate in Human aging in Barcelona, Spain and medical residencies and fellowships in the USA in Neurology, Anatomic Pathology, Neuropathology and Interventional Pain Medicine (Anesthesia based). This training required 10 additional years of post graduate medical education, all pursued in programs accredited by the American Board of Medical Specialties.
Dr. Pappolla's research interest is in the development of treatments for neurological degenerative disorders. He has patented and developed novel neuroprotective agents such as OX-1 (now on phase 2 trial for Friedriech ataxia) and melatonin related analogs for Alzheimer's disease.
Kumar Sambamurti, Padmaraju Vasudevaraju, Jacob Mintzer, David Bachman, Charlotte Granholm, Nigel Greig, Debomoy Lahiri and Miguel Pappolla
Editorial: J Alzheimers Dis 2012, 2:e115